INS and diabetes mellitus: Current anti-diabetes drugs are mainly aimed to correct hyperglycemia by promoting pancreatic β-cell insulin secretion, increasing insulin sensitivity, or reducing intestinal glucose uptake and hepatic gluconeogenesis.